newsfilter
← Latest News
FDA Approved Drugs·

Approval of Orlynvah, Nda #213972 (Type 1 - New Molecular Entity and Type 4 - New Combination)

Approval Date: 10/25/2024; Drug Name: Orlynvah, Nda #213972; Active Ingredients: SULOPENEM ETZADROXIL;PROBENECID; Company: Iterum Therapeutics Us Ltd; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity and Type 4 - New Combination; Application Number: 213972

Company
ITERUM THERAPEUTICS US LTD
Keywords
ITERUM THERAPEUTICS US LTD